Stocks Touched New Highs: GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), EDAP TMS S.A. (ADR) (NASDAQ:EDAP), Exactech (NASDAQ:EXAC), MannKind Corporation (NASDAQ:MNKD), Inogen (NASDAQ:INGN)

Recently, the United States Food and Drug Administration (FDA) has granted Fast Track designation to GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) investigational cannabidiol product, Epidiolex(R), in the treatment of Dravet syndrome, a rare and catastrophic treatment-resistant form of childhood epilepsy for which there is currently no cure. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) net profit margin is -25.00% and weekly performance is 14.42%. On last trading day company shares ended up $107.29. Analysts mean target price for the company is $99.00. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) distance from 50-day simple moving average (SMA50) is 46.90%.

EDAP TMS SA (NASDAQ:EDAP) on 27 June announced that the U.S. Food and Drug Administration (FDA) concluded its routine inspection of EDAP’s manufacturing site with no findings nor issuance of Form 483 observations. EDAP TMS S.A. (ADR) (NASDAQ:EDAP) shares advanced 12.16% in last trading session and ended the day on $4.98. EDAP gross Margin is 41.20% and its return on assets is -1.30%.EDAP TMS S.A. (ADR) (NASDAQ:EDAP) quarterly performance is 74.13%.

Exactech Inc. (NASDAQ:EXAC) EVP Gary J. Miller unloaded 16,356 shares of Exactech stock in a transaction dated Wednesday, June 25th. The shares were sold at an average price of $25.33, for a total value of $414,297.48. Following the completion of the sale, the executive vice president now directly owns 25,606 shares of the company’s stock, valued at approximately $648,600. Exactech, Inc. (NASDAQ:EXAC) shares moved down -0.08% in last trading session and was closed at $25.23, while trading in range of $24.87 – $26.52. Exactech, Inc. (NASDAQ:EXAC) year to date (YTD) performance is 6.19%.

MannKind Corporation (NASDAQ:MNKD) VP David Thomson sold 30,000 shares of the stock on the open market in a transaction that occurred on Thursday, June 26th. The shares were sold at an average price of $10.51, for a total transaction of $315,300.00. Following the transaction, the vice president now directly owns 102,286 shares in the company, valued at approximately $1,075,026. MannKind Corporation (NASDAQ:MNKD) ended the last trading day at $10.96. Company weekly volatility is calculated as 10.56% and price to cash ratio as 118.97.MannKind Corporation (NASDAQ:MNKD) showed a positive weekly performance of 2.14%.

Inogen Inc. (NASDAQ:INGN) announced on 24 June that it has received FDA clearance for home oxygen concentrator called the Inogen At Home. Inogen Inc. (NASDAQ:INGN) net profit margin is 0.10% and weekly performance is 17.87%. On last trading day company shares ended up $22.56. Analysts mean target price for the company is $26.00. Inogen Inc. (NASDAQ:INGN) distance from 50-day simple moving average (SMA50) is 36.66%.